Vedolizumab, an [alpha]4[beta]7-Integrin Inhibitor, Exacerbates Ulcerative Colitis-Related Spondylitis.doi:10.1097/RHU.0000000000002114Yamamoto, Hirotaka MDTaniguchi, Yoshinori MDLippincott Williams & WilkinsJCR: Journal of Clinical Rheumatology
Smith MA, Mohammad RA. Vedolizumab: an alpha4beta7 integrin inhibitor for inflammatory bowel diseases. Ann Pharmacother. 2014;48(12):1629–35.Smith MA, Mohammad RA. Vedolizumab: an alpha4beta7 integrin inhibitor for inflammatory bowel diseases[J]. Ann Pharmacother, 2014, 48(12): 1629-1635....